These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13817884)

  • 1. Prolonged survival of dystrophic mice treated with 17 alpha-ethyl-19-nortestosterone.
    DOWBEN RM
    Nature; 1959 Dec; 184(Suppl 25)():1966-7. PubMed ID: 13817884
    [No Abstract]   [Full Text] [Related]  

  • 2. Nandrolone-phenpropionate in progressive muscular dystrophy.
    BROWN IA; JAMES EM
    Arch Pediatr (N Y); 1961 Nov; 78():421-31. PubMed ID: 13873658
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
    BEKENY G; KRAFT F; LANG S
    Nervenarzt; 1960 Mar; 31():118-23. PubMed ID: 13798372
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
    BEKENY G; KRAFT F; LANG S
    Orv Hetil; 1960 Feb; 101():229-34. PubMed ID: 13798373
    [No Abstract]   [Full Text] [Related]  

  • 5. Methandrostenolone and nandrolone decanoate in muscular dystrophy; a controlled trial.
    BARWICK DD; NEWELL DJ; WALTON JN
    Neurology; 1963 Jan; 13():12-23. PubMed ID: 13969794
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of 17 alpha-ethyl-19-nortestosterone on the estrus cycle.
    RICHTER R
    Experientia; 1958 Jun; 14(6):219. PubMed ID: 13562067
    [No Abstract]   [Full Text] [Related]  

  • 7. The suppression of adrenocortical secretion with 17 alpha-ethyl-19-nortestosterone.
    BROOKS RB; PRUNTY FT
    J Endocrinol; 1957 Sep; 15(4):385-92. PubMed ID: 13475598
    [No Abstract]   [Full Text] [Related]  

  • 8. On the anticatabolic and anticalcinotic effects of 17-ethyl-19-nortestosterone.
    SELYE H; RENAUD S
    Am J Med Sci; 1958 Jan; 235(1):1-6. PubMed ID: 13487581
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the treatment of muscular diseases by anabolic steroids. II. Clinical experiences].
    HANTSCHMANN N; MATZELT D; MERTENS HG; NOWAKOWSKI H
    Dtsch Med Wochenschr; 1962 Dec; 87():2626-34. PubMed ID: 13952660
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of nandrolone, testosterone and their decanoate esters on murine lupus.
    Verheul HA; Stimson WH; den Hollander FC; Schuurs AH
    Clin Exp Immunol; 1981 Apr; 44(1):11-7. PubMed ID: 6973425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of 17-alpha-ethyl-19-nortestosterone on serum albumin and serum lipid concentration in nephrotic syndrome.
    GJORUP S; MUNCK O
    Acta Med Scand; 1959 Dec; 165():453-8. PubMed ID: 13828306
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of anorexia nervosa by ethyl-nortestosterone.
    CHALMERS TM; KEKWICK A; PAWAN GL
    Proc R Soc Med; 1959 Jul; 52():514-5. PubMed ID: 13809044
    [No Abstract]   [Full Text] [Related]  

  • 13. The myotrophic and androgenic effects of 17-ethyl-19-nortestosterone and related compounds.
    SAUNDERS FJ; DRILL VA
    Endocrinology; 1956 May; 58(5):567-72. PubMed ID: 13317831
    [No Abstract]   [Full Text] [Related]  

  • 14. Catabolic effect of dihydrotachysterol and anabolic action of 17-ethyl-19-nortestosterone on the uptake of radio sulphur in a healing fractured bone of the rat.
    KOWALEWSKI K
    Acta Endocrinol (Copenh); 1958 May; 28(1):119-23. PubMed ID: 13532383
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective action of 17-ethyl-19-nortestosterone against the inhibition of bone repair in the lathyrus-fed rat.
    KOWALEWSKI K; COUVES CM; LANG A
    Acta Endocrinol (Copenh); 1959 Feb; 30(2):268-72. PubMed ID: 13616925
    [No Abstract]   [Full Text] [Related]  

  • 16. Paradoxical response of metastatic breast cancer to 17-ethyl-19-nortestosterone.
    EMERSON K; MULLER J; de SOUZA ; LOUTFI G
    Ann Intern Med; 1961 Nov; 55():742-8. PubMed ID: 13890104
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of infantile dystrophy with 19-nortestosterone propionate].
    TROMBETTI E
    Rass Clin Ter; 1959; 58():215-22. PubMed ID: 13839458
    [No Abstract]   [Full Text] [Related]  

  • 18. Oestrogen antagonisms: the effects of testosterone propionate and 17-ethyl-19-nortestosterone on oestrone-induced changes in vaginal cytology.
    EDGREN RA
    Acta Endocrinol (Copenh); 1957 Aug; 25(4):365-70. PubMed ID: 13457747
    [No Abstract]   [Full Text] [Related]  

  • 19. Uptake of radiosulphur in growing bones of cockereis treated with cortisone and 17-ethyl-19-nortestosterone.
    KOWALEWSKI K
    Proc Soc Exp Biol Med; 1958 Feb; 97(2):432-6. PubMed ID: 13518296
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of 17-ethyl-19-nortestosterone on hyperglycemic action of glucagon in humans.
    WEISENFELD S
    Proc Soc Exp Biol Med; 1958 Apr; 97(4):764-7. PubMed ID: 13554475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.